Eli Lilly CEO David Ricks (Evan Vucci/AP Images)
Eli Lilly's David Ricks snared $24M pay package in a year turbo-boosted by Covid-19 antibody
Boosted by booming sales of its Covid-19 antibody bamlanivimab, Eli Lilly posted double-digit growth in 2020 despite a more steady showing from its legacy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.